Evidence map›Paper›PMID 41071033›Full record

ArticleTranslational vision science & technology2025

Archetypal Analysis Reveals Consistent Visual Field Patterns for Stimulus Size III and Size Modulation Perimetry in Glaucoma.

David Szanto, Edward Linton, Michael Wall

Abstract read
In one paragraph

Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David SzantoRenaissance School of Medicine, Stony Brook, NY, USA.
Edward LintonIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, IA, USA.
Michael WallIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, IA, USA.

Funding

Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
NEI NIH HHS R01 EY015473RRD VA I01 RX000140RRD VA I01 RX003797RRD VA I50 RX003002RRD VA IK1 RX005029
6 · The paper itself

Abstract

Purpose: Optic nerve disorders produce identifiable visual field (VF) patterns. Size modulation perimetry (SMP) unlike standard automated perimetry (SAP) shows little degradation of retest variability with increasing VF damage. We hypothesize that VF testing with stimulus size III (size III) and SMP would reveal analogous patterns, supporting interchangeability in clinical practice. Methods: We analyzed 274 same-day pairs of VFs from 83 eyes of patients with glaucoma. Participants underwent testing every 6 months using size III and SMP VFs. We converted raw sensitivity data to total deviation (TD) scores relative to normative datasets, censoring size III sensitivities below 20 decibels (dB). Archetypal analysis (AA) was applied separately to each modality to identify characteristic VF patterns, or archetypes (ATs). We evaluated both absolute VF patterns and longitudinal VF changes by subtracting baseline measurements. Cosine similarity measured the overlap between ATs in size III and SMP. Results: Absolute size III and SMP VFs exhibited overlapping patterns, with 95% of ATs demonstrating a cosine similarity of ≥0.50. Change ATs showed lower similarity scores (30% with cosine similarity ≥0.50). However, some ATs still revealed similar underlying defects. Conclusions: AA consistently extracted comparable VF defect patterns from size III and SMP in glaucoma. Absolute size III patterns closely aligned with SMP, whereas patterns of change showed partial agreement. Translational Relevance: These findings suggest that SAP and SMP capture similar patterns of VF loss.

Indexed as

GlaucomaVisual FieldsVisual Field TestsAgedFemaleHumansMaleMiddle Aged

Identifiers

PMID41071033
PMCPMC12524828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.